Stereotaxis, Inc. (STXS) - רווח נקי למניה (EPS TTM)

Stereotaxis, Inc. (STXS) operates in a stable environment with minimal political threats due to global demand for cardiac robots. Regular software and consumables sales drive business growth. The profit per unit trend over the last 12 months confirms this momentum, where -0.24 is the current value of the indicator. However, the final assembly of systems relies on external suppliers of electronics and sensors.

The efficiency of implementing Stereotaxis, Inc. (STXS) robotic systems in cardiac surgery converts directly into earnings per share, which measures the real investor income over the last 12 months after all expenses. By analyzing the TTM earnings per share snapshot on the GURU.Markets platform, one can distinguish sustainable capitalization growth from stagnation, thereby determining the fundamental value of a stake in the business.